US Stock MarketDetailed Quotes

NVZMY NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10

Watchlist
  • 55.760
  • +0.410+0.74%
15min DelayClose Apr 26 16:00 ET
25.89BMarket Cap35.63P/E (TTM)

NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Earnings Date

Currency: DKK

Period

Q4 FY2023 Earnings

Feb 1, 2024

Revenue(YoY)

4.60B

+1.63%
EPS(YoY)

2.51

-21.07%
Analyst Rating

Buy

Apr 27, 2024

NOVONESIS (NOVOZYMES) B UNSP ADR EACH REP 1 SER'B' DKK10 Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 28, 20242024/Q2-- / 7.096B--
--2024/Q1-- / 7.439B--
Feb 1, 20242023/Q44.603B / 4.598B--
Oct 26, 20232023/Q34.456B / 4.409B--
Aug 9, 20232023/Q24.217B / 4.347B--
Apr 26, 20232023/Q14.623B / 4.508B--
Jan 26, 20232022/Q44.529B / 4.492B--
Nov 3, 20222022/Q34.367B / 4.399B--
Aug 11, 20222022/Q24.286B / 4.085B--
Apr 26, 20222022/Q14.371B / 4.189B--
DatePeriodRevenue/EstimateEarnings Call
Aug 28, 20242024/Q2-- / 7.096B--
--2024/Q1-- / 7.439B--
Feb 1, 20242023/Q44.603B / 4.598B--
Oct 26, 20232023/Q34.456B / 4.409B--
Aug 9, 20232023/Q24.217B / 4.347B--
Apr 26, 20232023/Q14.623B / 4.508B--
Jan 26, 20232022/Q44.529B / 4.492B--
Nov 3, 20222022/Q34.367B / 4.399B--
Aug 11, 20222022/Q24.286B / 4.085B--
Apr 26, 20222022/Q14.371B / 4.189B--

Unlock Free Earnings Estimates

Analysis

Analyst Rating

Updated: Apr 27, 2024

Buy

  • Buy

    50.00%

  • Hold

    50.00%

  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg